Login to Your Account



Atyr raising $45.8M in equity financing to back lung, cancer programs

By Michael Fitzhugh
Staff Writer

Monday, August 28, 2017

Atyr Pharma Inc. is raising $45.8 million in equity financing through a private placement expected to help it advance both its pulmonary disease-focused iMod.Fc program and the preclinical Project Orca.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription